Data / Form D filings / K-V Pharmaceutical Co
K-V Pharmaceutical Co: Form D filings
K-V Pharmaceutical Co, a pharmaceuticals company in Chesterfield, MO, filed 5 Form D notices with the SEC between 2010 and 2013. The latest, on September 25, 2013, reports $260.9 million sold of a $260.9 million offering to 28 investors.
Find out what K-V Pharmaceutical Co does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 16640 Chesterfield Grove Road, Suite 200, Chesterfield, MO, 63005
- Phone
- (314) 645-6600
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 57055
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 25, 2013 | New notice | $260,877,100 | $260,877,100 | $0 | 28 | Jun 6, 2013 | sec.gov |
| Jun 18, 2012 | New notice | Indefinite | $210,000 | Indefinite | 1 | Jun 5, 2012 | sec.gov |
| Apr 1, 2011 | New notice | $225,000,000 | $225,000,000 | $0 | 104 | Mar 17, 2011 | sec.gov |
| Mar 4, 2011 | New notice | $32,337,500 | $32,337,500 | $0 | 12 | Feb 17, 2011 | sec.gov |
| Dec 6, 2010 | New notice | $7,552,506 | $7,552,506 | $0 | 2 | Nov 17, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joe J McGinnis | Director | |
| Patrick J Christmas | Executive Officer | |
| Steve J Nielson | Director | |
| Eric J Haron | Director | |
| Thomas S McHugh | Executive Officer | |
| Gregory J Divis | Executive Officer, Director | |
| Jonathan J Siegel | Director |
Other pharmaceuticals companies in Missouri that filed recently
- Immunophotonics, Inc. $10.1 million · Sep 4, 2026
Every Form D from the week of Sep 23, 2013 · All recent filings in Missouri · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what K-V Pharmaceutical Co reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.